xaliproden has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Joodi, G; Kleger, A; Mäder, K; Neumann, M; Niess, JH; Porzner, M; Seufferlein, T; von Boyen, G; Walldorf, J; Weissbach, J | 1 |
1 other study(ies) available for xaliproden and Colitis
Article | Year |
---|---|
The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis.
Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Humans; Intestinal Mucosa; Mice; Naphthalenes; Neuroglia; Pyridines; Serotonin 5-HT1 Receptor Agonists | 2022 |